Literature DB >> 32072588

Exact Unconditional Tests for Dichotomous Data When Comparing Multiple Treatments With a Single Control.

Guogen Shan1, Carolee Dodge-Francis2, Gregory E Wilding3.   

Abstract

In contemporary clinical trials, often evaluated simultaneously are multiple new treatments or the same treatment at multiple dose levels. These treatments are first compared with a control, and the best candidate with sufficient activity is then picked for the following trial for further investigation. When the primary outcome is binary, several testing procedures including Dunnett's test, have been proposed for the assessment of hypotheses. The sample size of each group is predetermined; thus, an unconditional exact approach is aligned with the study design. The exact unconditional approach based on maximization has been studied for comparing multiple treatments with a control. The newly developed exact unconditional approach based on estimation and maximization could possibly increase the effectiveness of exact approaches by smoothing the tail probability surface. We compare these 2 exact unconditional approaches based on 3 commonly used test statistics under various design settings. Based on results from numerical studies, we provide recommendations on the usage of these exact approaches. A real clinical trial to treat psoriasis is used to illustrate the application of the considered exact approaches.

Entities:  

Keywords:  Dunnett’s test; dichotomous data; exact test; multiple comparison; unconditional test

Mesh:

Year:  2020        PMID: 32072588     DOI: 10.1007/s43441-019-00070-w

Source DB:  PubMed          Journal:  Ther Innov Regul Sci        ISSN: 2168-4790            Impact factor:   1.778


  7 in total

1.  Two-stage optimal designs based on exact variance for a single-arm trial with survival endpoints.

Authors:  Guogen Shan
Journal:  J Biopharm Stat       Date:  2020-03-04       Impact factor: 1.051

2.  Randomized two-stage optimal design for interval-censored data.

Authors:  Guogen Shan
Journal:  J Biopharm Stat       Date:  2021-12-10       Impact factor: 1.503

3.  New Confidence Intervals for Relative Risk of Two Correlated Proportions.

Authors:  Natalie DelRocco; Yipeng Wang; Dongyuan Wu; Yuting Yang; Guogen Shan
Journal:  Stat Biosci       Date:  2022-05-20

4.  Optimal two-stage designs based on restricted mean survival time for a single-arm study.

Authors:  Guogen Shan
Journal:  Contemp Clin Trials Commun       Date:  2021-01-23

5.  Machine learning methods to predict amyloid positivity using domain scores from cognitive tests.

Authors:  Guogen Shan; Charles Bernick; Jessica Z K Caldwell; Aaron Ritter
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

6.  Monte Carlo cross-validation for a study with binary outcome and limited sample size.

Authors:  Guogen Shan
Journal:  BMC Med Inform Decis Mak       Date:  2022-10-17       Impact factor: 3.298

7.  Correlation Coefficients for a Study with Repeated Measures.

Authors:  Guogen Shan; Hua Zhang; Tao Jiang
Journal:  Comput Math Methods Med       Date:  2020-03-26       Impact factor: 2.238

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.